Page 2904 - Cote clinical veterinary advisor dogs and cats 4th

Boldface page numbers indicate chapter titles. Page numbers followed by a indicate algorithms; b, boxes; e, electronic content; f, figures; and t, tables. 1551

Peripheral nerve sheath tumor, 423, 714. See also Nerve Phenobarbital (Continued) Pilonidal sinus. See Pilonidal cyst
sheath tumor for amphetamine toxicosis, 50 Pimobendan
for canine distemper seizures, 272
for acute heart failure, 409
Peripheral neuropathy, 808
VetBooks.ir hyperlipidemia and, 497 for epilepsy, idiopathic, 302 administration and dosage of, 1499
as paraneoplastic syndrome, 754
for chronic heart failure, 411
for hepatic encephalopathy seizures, 441
tetraplegia/tetraparesis and, 967
for organophosphate and carbamate insecticide
for dilated cardiomyopathy, 265
Peripheral odontogenic fibroma, 306–307
toxicosis, 719
Peripheral vasomotor dysfunction, and syncope, 954 for salivary gland disorders, 896–897 drug interactions, 1510.e1t–1510.e5t
for myxomatous valve disease, 99
Periradicular abscess, 7 for seizures, 71, 198, 904 for restrictive cardiomyopathy, 882
Perirenal pseudocysts, 778.e2–778.e3 serum level of, 1372 for tricuspid valve dysplasia, 997
Perisymphyseal fracture, 362 toxicosis, 783.e3–783.e4 “Pince nez” cell, 1371
Peritoneal dialysis, 1151.e2–1151.e3 Phenol disinfectants toxicosis, 178–179 Pindone, 69
Peritoneal disease Phenol red-thread test, 569 Pine oil disinfectants toxicosis, 178–179
acute abdomen and, 22 Phenolics, 1217.e1 Pinna
dyspnea and, 1219 Phenoxy-type herbicide toxicosis, 464.e2–464.e3 alopecia of, 766, 790
Peritoneal drainage, 1056.e1–1056.e2, 1056.e2f Phenoxybenzamine diseases of, 789–790, 789f, 789.e1f
for uroabdomen, 1013 administration and dosage of, 1499 hematoma of, 104–105, 790
Peritoneal effusion. See Ascites for feline lower urinary tract signs, 333t marginal dermatosis of, 215–216
Peritoneal fluid accumulation. See Ascites for pheochromocytoma, 786 Pinnal-pedal reflex, 790, 900–901
Peritoneal lavage, diagnostic, 780 for reflex dyssynergia, 872 Piperacillin-tazobactam, 1499
Peritoneal space, 1155.e5 for tick paralysis, 977 Pipracil. See Piperacillin
Peritoneopericardial diaphragmatic hernia, 778–779, 779f for urethral obstruction, 1010 Piroplasmosis. See Babesiosis
Peritonitis, 779.e2–779.e4, 1267 for urinary bladder atony/hypotonia, 90 Piroxicam
feline infectious. See Feline infectious peritonitis (FIP) Phentermine. See Amphetamine toxicosis administration and dosage of, 1499
septic, 779–780, 1267, 1439a Phentolamine, for hypertension, 784 for oral tumors, malignant, 715
Periuria, 332 Phenylbutazone toxicosis, 696 for prostatic neoplasia, 829
Permethrin-imidacloprid, for tick control, 978.e3 Phenylephrine, 2 for renal neoplasia, 877
Persian cat administration and dosage of, 1499 for squamous cell carcinoma, 941
alopecia in, 45 toxicosis from, 240–241 toxicosis from, 696
cataracts in, 147 Phenylpropanolamine (PPA) for transitional cell carcinoma, 992
cerebellar cortical degeneration in, 149.e3 administration and dosage of, 1499 Pit bull. See American pit bull terrier
corneal sequestration in, 208 drug interactions, 1510.e1t–1510.e5t Pit viper envenomation, 923–925, 925f
cutaneous neoplasia in, 230 for hormone-responsive incontinence, 1012 Pitocin. See Oxytocin
cutaneous/subcutaneous masses in, 628 toxicosis, 784–785 Pitressin. See Vasopressin
dermatophytosis in, 247 for vaginitis, 1031 Pituitary-dependent hyperadrenocorticism. See
familial nephropathy in, 169 Phenytoin, 777, 1499. See also Phenylpropanolamine Hyperadrenocorticism
immunodeficiency syndrome in, 530.e3 Pheochromocytoma, 785–786 Pituitary dwarfism, 790.e2–790.e3
lower urinary tract signs in, 332 diagnostic algorithm for, 1439.e4a alopecia and, 1195–1196
mammary gland neoplasia in, 621 panting and, 751 stunted growth and, 947
neonatal losses in, 687 Pheromones, Dog Appeasing, 1152 Pituitary macroadenoma, 485
patellar luxation in, 763 Phimosis, paraphimosis and, 756.e4 Pivampicillin, 3
peritoneopericardial diaphragmatic hernia in, 778 Phlebotomus, 580 PIVKA. See Proteins induced by Vitamin K absence or
persistent Müllerian duct syndrome in, 780.e3 Phlebotomy, 1151.e4–1151.e6, 1151.e5f–1151.e6f antagonism (PIVKA)
pigmentary abnormalities in, 195 for Eisenmenger’s syndrome, 288.e3 PKD. See Polycystic kidney disease (PKD)
platelet dysfunction in, 790.e5 for hyperviscosity syndrome, 511 Placental sites, subinvolution of, 950–951, 951f, 951.e1f
polycystic kidney disease in, 805 for patent ductus arteriosus, type 4, 765 Plague, 790.e3–790.e5
renomegaly in, 879.e3 for polycythemia vera, 807 Planned exposure, 467
restrictive/unclassified cardiomyopathy in, 881 for tetralogy of Fallot, 966 Plant foreign bodies, of respiratory tract, 355–357
seborrhea oleosa in, 214 Phobias, 787–788 Plant toxicosis, 1267–1268. See also specific plants
temporomandibular joint dysplasia in, 961.e3 Phorate, 718 Brunfelsia spp., 138.e6–138.e7
urolithiasis in, 1014 Phosphate-binding agents. See also specific agents cardiotoxic, 143–144, 144.e1f, 707–708, 707.e1f
Persistent deciduous teeth, 617–618 for chronic kidney disease, 170 castor bean, 147.e2–147.e3
Persistent erection, 821.e2 for phosphate enema toxicosis, 788.e2 oleander, 706–707, 707.e1f
Persistent estrus, 822 for renal secondary hyperparathyroidism, 879 onion or garlic, 707–708
Persistent fontanelle, hydrocephalus and, 482 Phosphate enemas, 1099 palm, 737–738, 738.e1f
Persistent frenulum, 780.e2, 780.e2f toxicosis from, 788.e2–788.e3 Plasma, fresh frozen. See Fresh frozen plasma
Persistent Müllerian duct syndrome, 780.e3 Phosphine gas, 1051–1052 Plasma cell pododermatitis, 350, 351f
Persistent primary teeth, 1089 Phosphodiesterase-5 inhibitors, 288.e3 Plasma cell tumor, 663–665, 893, 894.e1f. See also
Persistent pupillary membranes, 563–564 Phosphofructokinase deficiency, and hemolytic anemia, Plasmacytoma
Persistent “puppy coat”, 525 59 Plasma exchange, 431.e3
Persistent right aortic arch, 1031.e2 Phosphorus Plasma osmolality, in diabetes insipidus, 250
Perthes disease. See Aseptic necrosis of femoral head radioactive, for polycythemia vera, 807 Plasma proteins. See Total protein
Pesticides, in adulterated diets, 37t serum, 1372–1373. See also Hyperphosphatemia; Plasma transfusion
Petechiae, 781–782, 1267.e1, 1439.e3a Hypophosphatemia for systemic inflammatory response syndrome, 955.e5
Petit basset griffon Vendéen, epilepsy in, 903 Phthisis bulbi, 705–706 for von Willebrand disease, 1044
Petroleum distillates toxicosis, 782–783 Physaloptera spp., 380.e2–380.e3 Plasmacytoma, 663. See also Plasma cell tumor
Petroleum hydrocarbons, 782 Physical abuse, 9 gastric extramedullary, 379
pH Physical rehabilitation, 1151.e7–1151.e8, 1151.e8f oral, 712
blood, 1315–1316 Physiologic heart murmurs, 413–414 Plasmalyte 56, 1510.e8t
urine, 1391–1392 Physiotherapy. See Chest physiotherapy; Physical Plasmalyte 148, 1510.e8t
Phacodonesis, 581 rehabilitation Plasmapheresis
Phacoemulsification, for lens luxation, 582 Physostigmine for hyperviscosity syndrome, 511, 664
Phaeohyphomycosis, 372–373 for ivermectin toxicosis, 567, 1200t–1201t for polyradiculoneuritis, 811
Phalangeal disorders, 783.e1–783.e2, 783.e1f–783.e2f for narcolepsy testing, 676.e1 Platelet(s), 1373
Phalanx, third, bony lysis of, 177 Phytates, 1054.e2 decreased. See Thrombocytopenia
Phallocampus, 780.e2 Phytonadione. See Vitamin K 1 dysfunction of. See Platelet dysfunction
Pharyngeal dysphagia, 277 Pigeon-toed, 763 increased. See Thrombocytosis
Pharyngeal examination, 1125–1127, 1126f Pigmentary abnormalities lyophilized canine, 1171–1172
Pharyngeal salivary mucocele, 6 of coat, 195–197, 196f per high power field, normal range, 1373
Phenazopyridine, and keratoconjunctivitis sicca, 569 nasal, 677 Platelet dysfunction, 790.e5–790.e6, 1373
Phendimetrazine. See Amphetamine toxicosis of skin, 195–197, 196f immune-mediated hemolytic anemia and, 62
Phenmetrazine. See Amphetamine toxicosis Pigmentary keratitis, 205.e2, 206, 207f Platelet plug formation, 433
Phenobarbital Pilocarpine ophthalmic solution, for keratoconjunctivitis Platelet-rich plasma, 910, 913
administration and dosage of, 1499 sicca, 569 Platelet–derived growth factor, 509
adverse effects of, 783.e3–783.e4 Pilonidal cyst, 788.e3–788.e4, 788.e4f Platinol. See Cisplatin
www.ExpertConsult.com